IE
QTTB icon

Israel Englander’s Q32 Bio QTTB Stock Holding History

Israel Englander’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Buy
+10,928
New +$91.3K ﹤0.01% 5414
2026
Q1 		– Sell
-51,268
Closed -$170K – 6497
2025
Q4 		$170K Sell
51,268
-53,504
-51% -$151K ﹤0.01% 5513
2025
Q3 		$207K Sell
104,772
-25,607
-20% -$49.2K ﹤0.01% 5529
2025
Q2 		$194K Buy
+130,379
New +$222K ﹤0.01% 5373
2025
Q1 		– Sell
-10,725
Closed -$36.9K – 6501
2024
Q4 		$36.9K Sell
10,725
-89,618
-89% -$2.83M ﹤0.01% 5633
2024
Q3 		$4.48M Buy
+100,343
New +$3.69M ﹤0.01% 2938
2024
Q1 		– Sell
-960
Closed -$10.5K – 6739
2023
Q4 		$10.5K Sell
960
-5,622
-85% -$82.2K ﹤0.01% 5734
2023
Q3 		$139K Sell
6,582
-3,530
-35% -$72K ﹤0.01% 5244
2023
Q2 		$161K Sell
10,112
-1,537
-13% -$27.6K ﹤0.01% 5201
2023
Q1 		$216K Sell
11,649
-1,740
-13% -$43.3K ﹤0.01% 5129
2022
Q4 		$304K Sell
13,389
-12,138
-48% -$322K ﹤0.01% 5098
2022
Q3 		$740K Sell
25,527
-14,582
-36% -$595K ﹤0.01% 4598
2022
Q2 		$1.42M Buy
+40,109
New +$1.37M ﹤0.01% 4042
2022
Q1 		– Sell
-11,620
Closed -$761K – 7590
2021
Q4 		$761K Buy
11,620
+4,586
+65% +$445K ﹤0.01% 4668
2021
Q3 		$996K Sell
7,034
-8,960
-56% -$1.14M ﹤0.01% 4693
2021
Q2 		$2.09M Buy
15,994
+2,190
+16% +$273K ﹤0.01% 3901
2021
Q1 		$2.34M Buy
13,804
+4,637
+51% +$976K ﹤0.01% 3385
2020
Q4 		$1.86M Buy
9,167
+1,850
+25% +$358K ﹤0.01% 3294
2020
Q3 		$1.41K Sell
7,317
-3,904
-35% -$875K ﹤0.01% 2875
2020
Q2 		$3.07M Buy
11,221
+9,838
+711% +$2.62M ﹤0.01% 2199
2020
Q1 		$387K Sell
1,383
-1,776
-56% -$544K ﹤0.01% 3030
2019
Q4 		$1.18M Buy
+3,159
New +$905K ﹤0.01% 2933
2019
Q3 		– Sell
-1,153
Closed -$406K – 4620
2019
Q2 		$406K Buy
+1,153
New +$453K ﹤0.01% 3364
2018
Q2 		– Sell
-5,051
Closed -$1.7M – 4243
2018
Q1 		$1.7M Buy
+5,051
New +$1.7M ﹤0.01% 2414

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's QTTB Position: Q2 2026 in Review

Israel Englander opened a new position in Q32 Bio (QTTB) in Q2 2026: 10,928 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #5414 among its holdings. This is a return to the name: Israel Englander previously reported a position in QTTB as recently as Q4 2025.

Israel Englander first reported a position in QTTB in Q1 2018 and has held it in 24 quarters since. The position peaked at $4.48M in Q3 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Israel Englander held 10,928 shares of Q32 Bio worth $139K as of Q2 2026.
  • Q32 Bio was a new Israel Englander position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5414 holding.
  • Israel Englander first reported a position in Q32 Bio in Q1 2018 and has held it in 24 quarters since.
  • Israel Englander's Q32 Bio position peaked at $4.48M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.